Endo International (ENDP) Tops Q4 EPS by 16c, FY EPS Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Endo Reports Fourth-Quarter And Full Year 2018 Financial Results
February 28, 2019 6:30 AM ESTDUBLIN, Feb. 28, 2019 /PRNewswire/ --
Fourth-quarter 2018 revenues increased 2 percent to $786 million Fourth-quarter 2018 Sterile Injectables revenues increased 32 percent to $259 million Fourth-quarter 2018 XIAFLEX® franchise revenues increased 30 percent to $80 million Company expects 2019 revenues to range between $2.76 billion and $2.96 billion and 2019 adjusted EBITDA between $1.24 billion and $1.34 billionEndo International plc (NASDAQ: ENDP) today reported fourth-quarter 2018 financial results, including:
Revenues of $786 million, an increase of 2 percent compared to fourth-quarter 2017 revenues of $769 million; revenues increased 5 percent compared to third-quarter 2018. Reported net... More